Inclusion criteria for these data.
Click here to view these tables as graphics.
| CONDITION OR DISORDER | INTERVENTION | EVENTS BEING PREVENTED | CER | EER | DURATION OF FOLLOW-UP | NNT |
|---|---|---|---|---|---|---|
| Eclampsia | Magnesium sulphate compared with diazepam | Recurrent convulsions | 27.9% | 13.2% | Hours | 7 |
Evidence-Based Medicine 1996;1(2):44. | ||||||
| Eclampsia | Magnesium sulphate compared with phenytoin | Recurrent convulsions | 17.1% | 5.7% | Hours | 9 |
Evidence-Based Medicine 1996;1(2):44. | ||||||
| Women with hypertension hospitalised in labour | Magnesium suplhate compared with phenytoin | Seizures | 0.9% | 0% | Hours | 109 |
Evidence-Based Medicine 1996;1(2):45. | ||||||
| Labour and delivery | Routine intrapartum electronic foetal monitoring compared with intermittent ausculatation | Neonatal seizures | 0.49% | 0.24% | Hours | 409 |
Evidence-Based Medicine 1996;1(3):93. | ||||||
| Pre-term labour | Adrenal corticosteroids | Respiratory distress syndrome | 23% | 13% | 11 | |
Evidence-Based Medicine 1996;1(3):92. | ||||||
| Women giving birth | Care from a midwife team compared with that of routine care | Medical intervention | 36% | 24% | 6 weeks | 9 |
Evidence-Based Medicine 1996;1(3):94. | ||||||
To add to this collection, click on the comment icon below:
